BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15339861)

  • 1. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.
    Christians U; Gottschalk S; Miljus J; Hainz C; Benet LZ; Leibfritz D; Serkova N
    Br J Pharmacol; 2004 Oct; 143(3):388-96. PubMed ID: 15339861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism.
    Klawitter J; Gottschalk S; Hainz C; Leibfritz D; Christians U; Serkova NJ
    Chem Res Toxicol; 2010 Mar; 23(3):608-19. PubMed ID: 20148532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain.
    Serkova N; Jacobsen W; Niemann CU; Litt L; Benet LZ; Leibfritz D; Christians U
    Br J Pharmacol; 2001 Jul; 133(6):875-85. PubMed ID: 11454661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
    Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
    Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of cyclosporin a on the metabolism of perfused rat brain slices during normoxia and hypoxia.
    Serkova N; Donohoe P; Gottschalk S; Hainz C; Niemann CU; Bickler PE; Litt L; Benet LZ; Leibfritz D; Christians U
    J Cereb Blood Flow Metab; 2002 Mar; 22(3):342-52. PubMed ID: 11891440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.
    Gottschalk S; Cummins CL; Leibfritz D; Christians U; Benet LZ; Serkova NJ
    Neurotoxicology; 2011 Jan; 32(1):50-7. PubMed ID: 21075140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy.
    Serkova N; Litt L; James TL; Sadée W; Leibfritz D; Benet LZ; Christians U
    J Pharmacol Exp Ther; 1999 May; 289(2):800-6. PubMed ID: 10215655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.
    Niemann CU; Saeed M; Akbari H; Jacobsen W; Benet LZ; Christians U; Serkova N
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1123-8. PubMed ID: 12183671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F
    J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
    Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
    PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation.
    Venet F; Demaret J; Blaise BJ; Rouget C; Girardot T; Idealisoa E; Rimmelé T; Mallet F; Lepape A; Textoris J; Monneret G
    J Immunol; 2017 Sep; 199(5):1606-1615. PubMed ID: 28724580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats.
    Shing CM; Fassett RG; Brown L; Coombes JS
    Transpl Int; 2012 Mar; 25(3):337-46. PubMed ID: 22239125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus.
    Lamoureux F; Picard N; Boussera B; Sauvage FL; Marquet P
    Fundam Clin Pharmacol; 2012 Aug; 26(4):463-72. PubMed ID: 21631587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells.
    Jesus TT; Oliveira PF; Silva J; Barros A; Ferreira R; Sousa M; Cheng CY; Silva BM; Alves MG
    Fertil Steril; 2016 Mar; 105(3):825-833.e3. PubMed ID: 26698679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat.
    Serkova N; Klawitter J; Niemann CU
    Transpl Int; 2003 Oct; 16(10):748-55. PubMed ID: 12827232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mTOR inhibitor sirolimus suppresses renal, hepatic, and cardiac tissue cellular respiration.
    Albawardi A; Almarzooqi S; Saraswathiamma D; Abdul-Kader HM; Souid AK; Alfazari AS
    Int J Clin Exp Pathol; 2015; 8(3):2955-62. PubMed ID: 26045804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
    Wowro SJ; Schmitt KRL; Tong G; Berger F; Schubert S
    Int Immunopharmacol; 2016 Jan; 30():9-17. PubMed ID: 26613512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
    Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P
    Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.